The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

UK BROKER RATINGS SUMMARY: UBS Cuts RBS; Goldman Says Buy Prudential

Tue, 29th Oct 2019 09:17

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

----------

FTSE 100

----------

UBS CUTS RBS TO 'NEUTRAL' ('BUY') - TARGET 235 (255) PENCE

----------

BARCLAYS CUTS HSBC PRICE TARGET TO 600 (610) PENCE - 'UNDERWEIGHT'

----------

CREDIT SUISSE CUTS HSBC PRICE TARGET TO 655 (680) PENCE - 'NEUTRAL'

----------

DZ BANK CUTS FAIR VALUE FOR HSBC TO 500 (560) PENCE - 'SELL'

----------

GOLDMAN REINITIATES PRUDENTIAL WITH 'BUY' - PRICE TARGET 1560 PENCE

----------

EVERCORE ISI CUTS PRUDENTIAL PRICE TARGET TO 1600 (1850) PENCE - 'OUTPERFORM'

----------

KEPLER CHEUVREUX RAISES ASTRAZENECA PRICE TARGET TO 8000 (7700) PENCE - 'BUY'

----------

UBS RAISES ASTRAZENECA PRICE TARGET TO 5800 (5700) PENCE - 'SELL'

----------

GOLDMAN RAISES PERSIMMON PRICE TARGET TO 2442 (2418) PENCE - 'BUY'

----------

HSBC RAISES AUTO TRADER GROUP PRICE TARGET TO 535 (465) PENCE - 'HOLD'

----------

JEFFERIES RAISES J SAINSBURY PRICE TARGET TO 220 (200) PENCE - 'HOLD'

----------

GOLDMAN CUTS POLYMETAL PRICE TARGET TO 1300 (1310) PENCE - 'BUY'

----------

FTSE 250

----------

UBS CUTS SYNTHOMER PRICE TARGET TO 290 (310) PENCE - 'NEUTRAL'

----------

BARCLAYS RAISES GVC HOLDING PRICE TARGET TO 1050 (913) PENCE - 'OVERWEIGHT'

----------

GOLDMAN RAISES KAZ MINERALS PRICE TARGET TO 500 (475) PENCE - 'NEUTRAL'

----------

JEFFERIES RAISES ULTRA ELECTRONICS PRICE TARGET TO 2000 (1775) PENCE - 'HOLD'

----------

JPMORGAN CUTS CAIRN ENERGY PRICE TARGET TO 268 (272) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS ROYAL MAIL TO 'UNDERWEIGHT' ('NEUTRAL') - TARGET 192 (252) PENCE

----------

RBC CUTS HASTINGS GROUP PRICE TARGET TO 165 (170) PENCE - 'UNDERPERFORM'

----------

Copyright 2019 Alliance News Limited. All Rights Reserved.

Related Shares

More News
Today 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announ...

3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.